Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection

Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection

ABSTRACTThe H7N9 influenza virus has been circulating in China for more than six years. The neuraminidase (NA) has gained great concern for the development of antiviral drugs, therapeutic antibodies, and new vaccines. In this study, we screened seven mouse monoclonal antibodies (mAbs) and compared t...

Full description

Bibliographic Details
Main Authors: Fei-Fei Xiong, Xue-Ying Liu, Fei-Xia Gao, Jian Luo, Peng Duan, Wen-Song Tan, Ze Chen
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Emerging Microbes and Infections
Subjects:
H7N9 influenza virus
neuraminidase
monoclonal antibodies
protection
NA epitope
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2019.1708214

Internet

https://www.tandfonline.com/doi/10.1080/22221751.2019.1708214

Similar Items